Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
Seminars in Liver Disease|May 1, 2014
Interferon-free strategies with a nucleoside/nucleotide analogueJordan J Feld
Antiviral Research|February 20, 2014
The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?Jordan J Feld
Journal of Hepatology|February 15, 2020
HCV elimination: It will take a village and then someJordan J Feld
Gastroenterology|April 28, 2012
Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?Jordan J Feld
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infectionJordan J Feld
Clinical Liver Disease|April 18, 2019
Resistance testing: Interpretation and incorporation into HCV treatment algorithmsJordan J Feld
The Journal of Infectious Diseases|October 13, 2023
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?Jordan J Feld
Clinical Liver Disease|April 17, 2019
Hepatitis C Virus Diagnostics: The Road to SimplificationJordan J Feld
Digestive Diseases (Basel, Switzerland)|May 4, 2017
Hepatitis B Reactivation: The Controversies ContinueJordan J Feld
Clinical Liver Disease|April 18, 2019
HBV treatment in a patient who will be receiving immunosuppressive therapyJordan J Feld
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
Seminars in Liver Disease|May 1, 2014
Interferon-free strategies with a nucleoside/nucleotide analogueJordan J Feld
Antiviral Research|February 20, 2014
The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?Jordan J Feld
Journal of Hepatology|February 15, 2020
HCV elimination: It will take a village and then someJordan J Feld
Gastroenterology|April 28, 2012
Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?Jordan J Feld
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infectionJordan J Feld
Clinical Liver Disease|April 18, 2019
Resistance testing: Interpretation and incorporation into HCV treatment algorithmsJordan J Feld
The Journal of Infectious Diseases|October 13, 2023
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?Jordan J Feld
Clinical Liver Disease|April 17, 2019
Hepatitis C Virus Diagnostics: The Road to SimplificationJordan J Feld
Digestive Diseases (Basel, Switzerland)|May 4, 2017
Hepatitis B Reactivation: The Controversies ContinueJordan J Feld
Clinical Liver Disease|April 18, 2019
HBV treatment in a patient who will be receiving immunosuppressive therapyJordan J Feld
Pageof 40